<%@ Page Language="C#" %>

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<script runat="server">

</script>

<html xmlns="http://www.w3.org/1999/xhtml">
<head runat="server">
    <title>Untitled Page</title>
    <style type="text/css">

        .style1
        {
            width: 100%;
            height: 521px;
        }
        .style3
        {
            width: 224px;
            height: 128px;
        }
        .style4
        {
            height: 128px;
        }
        .style2
        {
            width: 224px;
        }
        .style5
        {
            width: 224px;
            height: 144px;
        }
        .style6
        {
            height: 144px;
        }
        .style7
        {
            width: 224px;
            height: 45px;
        }
        .style8
        {
            height: 45px;
        }
    </style>
</head>
<body>
    <form id="form1" runat="server">
    <div>
    
        <table border="2" class="style1">
            <tr>
                <td class="style7">
                    Last updated</td>
                <td class="style8">
                    Monday, 06, August, 2007</td>
            </tr>
            <tr>
                <td class="style3">
                    Specimen:                 </td>
                <td class="style4">
                    5 mL blood in plain tube on melting ice, or blood spots on kit filter paper. </td>
            </tr>
            <tr>
                <td class="style2">
                    Method:</td>
                <td>
                    Competitive binding assay using radio-labelled alpha-bungarotoxin acetylcholine 
                    receptor. Radio-immunoassay using cell lines</td>
            </tr>
            <tr>
                <td class="style2">
                    Reference Interval:</td>
                <td>
                    Qualitative test. Positive result is significant</td>
            </tr>
            <tr>
                <td class="style2">
                    Application :</td>
                <td>
                    Diagnosis of myasthenia gravis; monitoring disease activity</td>
            </tr>
            <tr>
                <td class="style5">
                    Interpretation:</td>
                <td class="style6">
                    More than 90% of patients with generalised myasthenia gravis and about 60% of 
                    those with ocular myasthenia have detectable acetylcholine receptor antibodies. 
                    The test is positive in less than 1% of non-myasthenic individuals and a 
                    positive result usually indicates a related disorder.</td>
            </tr>
            <tr>
                <td class="style2">
                    Reference:
                </td>
                <td>
                    Drachman, Daniel B. Medical progress: myasthenia gravis. N Engl J Med 1994; 330: 
                    1797-810.</td>
            </tr>
        </table>
    
    </div>
    </form>
</body>
</html>
